Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

EVERSANA heads to Washington, DC for NORD Rare Summit

A team of EVERSANA experts will be in Washington, DC today for the National Organization for Rare Disorders’ (NORD) 2018 Rare Summit.  They will join more than 700 leaders from the FDA, NIH, industry, patient groups, payers and research institutions to address the industry’s shift to patient-centered, value-based care.

“We’re proud of our long standing partnership with NORD as they share our commitment to this important community. Every day, we are supporting our clients’ patients as they navigate the challenges of rare disease,” shares Kathi Henson, president of patient services, EVERSANA. “All stakeholders need to work together to bring more orphan therapies to market, and provide the services and support patients and caregivers deserve.”

The two-day summit takes place October 15-16. For more information, visit NORD.